0 Ratings
ID

42996

Description

Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609

Link

http://clinicaltrials.gov/ct2/show/record/NCT00661609

Keywords

Versions (3)
  1. 11/18/11 11/18/11 -
  2. 3/26/14 3/26/14 - Martin Dugas
  3. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility DRKS00004052 NCT00661609 Bladder Cancer

    English

    Eligibility Advanced Bladder Cancer NCT00661609

    1 forms  
    Inclusion criteria
    Description

    Inclusion criteria

    Alias
    UMLS CUI-1
    C1512693
    Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
    Description

    Urothelial Neoplasm

    Data type

    boolean

    Alias
    UMLS CUI-1
    C1519840
    Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
    Description

    Stage IV

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0441772
    Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
    Description

    Prior chemotherapy

    Data type

    boolean

    Alias
    UMLS CUI-1
    C1514457
    Ambulatory and capable of all selfcare more than 50% of waking hours
    Description

    General status

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0947124
    Exclusion criteria
    Description

    Exclusion criteria

    Alias
    UMLS CUI-1
    C0680251
    Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
    Description

    Prior treatment

    Data type

    boolean

    Alias
    UMLS CUI-1
    C1514463
    Inadequate bone marrow reserve
    Description

    Inadequate bone marrow reserve

    Data type

    boolean

    Alias
    UMLS CUI-1
    CL406855
    Inadequate liver function in the presence of liver metastases
    Description

    Liver Dysfunction

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0086565
    Impaired renal function
    Description

    Impaired renal function

    Data type

    boolean

    Alias
    UMLS CUI-1
    C1565489
    Back to the top of the page

    Similar models

    Eligibility Advanced Bladder Cancer NCT00661609

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Inclusion criteria
    C1512693 (UMLS CUI-1)
    Urothelial Neoplasm
    Item
    Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra)
    boolean
    C1519840 (UMLS CUI-1)
    Stage IV
    Item
    Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
    boolean
    C0441772 (UMLS CUI-1)
    Prior chemotherapy
    Item
    Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting
    boolean
    C1514457 (UMLS CUI-1)
    General status
    Item
    Ambulatory and capable of all selfcare more than 50% of waking hours
    boolean
    C0947124 (UMLS CUI-1)
    Item Group
    Exclusion criteria
    C0680251 (UMLS CUI-1)
    Prior treatment
    Item
    Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication, 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
    boolean
    C1514463 (UMLS CUI-1)
    Inadequate bone marrow reserve
    Item
    Inadequate bone marrow reserve
    boolean
    CL406855 (UMLS CUI-1)
    Liver Dysfunction
    Item
    Inadequate liver function in the presence of liver metastases
    boolean
    C0086565 (UMLS CUI-1)
    Impaired renal function
    Item
    Impaired renal function
    boolean
    C1565489 (UMLS CUI-1)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial